Probiotics' preventive effect on pediatric food allergy: a meta-analysis of randomized controlled trials

Xiang-yi Kong1, Yi Yang1, Jian Guan1

  • 1Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

Insights

Probiotic supplementation during pregnancy and after birth did not significantly prevent pediatric food allergies. Current evidence is insufficient to confirm a preventive effect of probiotics on these conditions.

Area of Science:

  • Immunology
  • Gastroenterology
  • Pediatrics

Background:

  • Food allergies are a growing concern in pediatric populations.
  • The role of gut microbiota in immune system development and allergy prevention is under investigation.
  • Probiotics, live microorganisms conferring a health benefit, are explored for their potential to modulate the immune response.

Purpose of the Study:

  • To evaluate the efficacy of probiotic supplementation in preventing the development of food allergies in children.
  • To synthesize evidence from randomized controlled trials (RCTs) on this topic.

Main Methods:

  • A systematic review and meta-analysis of RCTs was conducted.
  • Studies were identified through MEDLINE up to September 2013.
  • Data from homogenous studies were pooled using a fixed-effects model to calculate relative risk (RR).

Main Results:

  • Ten RCTs involving 2701 children were included in the meta-analysis.
  • Prenatal and postnatal probiotic supplementation showed no significant preventive effect on pediatric food allergies (RR = 0.88, 95% CI: 0.76-1.03).

Conclusions:

  • The current body of evidence does not unequivocally support the use of probiotics for preventing food allergic diseases in children.
  • Further high-quality research may be needed to clarify the role of probiotics in allergy prevention.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
286
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
394
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
941
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
58
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398